Methylated HBHA Produced in M. smegmatis Discriminates between Active and Non-Active Tuberculosis Disease among RD1-RespondersGiovanni Delogu, Delia Goletti, F. Lauria et al.|PLoS ONE|2011Cited by 79
Immune characterization of the HBHA-specific response in Mycobacterium tuberculosis-infected patients with or without HIV infectionTeresa Chiacchio, Delia Goletti, Giovanni Delogu et al.|PLoS ONE|2017Cited by 46
Combined use of Quantiferon and HBHA-based IGRA supports tuberculosis diagnosis and therapy management in childrenMichela Sali, Giovanni Delogu, Danilo Buonsenso et al.|Journal of Infection|2018Cited by 43
Lack of Response to <scp>HBHA</scp> in <scp>HIV</scp>‐Infected Patients with Latent Tuberculosis InfectionGiovanni Delogu, Delia Goletti, Valentina Vanini et al.|Scandinavian Journal of Immunology|2016Cited by 27